do-me/EUR-LEX huggingface dataset:
Case T-549/22: Action brought on 6 September 2022 — Prolactal v EUIPO — Prolàctea (PROLACTAL)
Date: 2022-09-06
Institutions: General Court
Subjects: EU trade mark, advertising, animal product, baby food, beverage, confectionery, milk product, processed foodstuff, registered trade mark, trade-mark law








C_2022408EN.01004002.xml










24.10.2022   


EN


Official Journal of the European Union


C 408/40






Action brought on 6 September 2022 — Prolactal v EUIPO — Prolàctea (PROLACTAL)
(Case T-549/22)
(2022/C 408/54)
Language in which the application was lodged: English

Parties


Applicant: Prolactal GmbH (Hartberg, Austria) (represented by: H. Roerdink and S. Janssen, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Prolàctea, SAU (Castrogonzalo, Spain)

Details of the proceedings before EUIPO


Proprietor of the trade mark at issue: Applicant before the General Court

Trade mark at issue: International registration designating the European Union in respect of the mark PROLACTAL — International registration designating the European Union No 1 475 897

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 10 June 2022 in Case R 752/2021-5

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision insofar as it relates to Prolactal;










—


order EUIPO to pay the costs of the proceedings.





Pleas in law







—


Infringement of Article 27(4) of Commission Delegated Regulation (EU) 2018/625;










—


Infringement of the principles of the protection of legitimate expectations and legal certainty, on the ground that the EUIPO’s decision that the requests for proof of use filed by Prolactal do not comply with the requirements of Article 10(1) EUTMDR, and are thus inadmissible, is not proportional to the consequences thereof;










—


Infringement of Article 7(1)(c) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;










—


Infringement of Article 94 of Regulation (EU) 2017/1001 of the European Parliament and of the Council and of Article 41(2) of the Charter of Fundamental Rights of the European Union;










—


Infringement of the principles of the protection of legitimate expectations and legal certainty as the burden of proof imposed by EUIPO went beyond the scope of what could be expected from the applicant to provide as evidence for coexistence;










—


Infringement of relevant case-law with regard to the overall assessment of the likelihood of confusion.
Case T-179/22: Order of the General Court of 6 September 2022 — Farco-Pharma v EUIPO — Infarco (FARCO) (EU trade mark — Opposition proceedings — Withdrawal of the opposition — No need to adjudicate)
Date: 2022-09-06
Institutions: General Court
Subjects: EU trade mark, dietary product, herbicide, pesticide, pharmaceutical product, registered trade mark, trade-mark law, veterinary medicinal product








C_2022418EN.01003602.xml










31.10.2022   


EN


Official Journal of the European Union


C 418/36






Order of the General Court of 6 September 2022 — Farco-Pharma v EUIPO — Infarco (FARCO)
(Case T-179/22) (1)

(EU trade mark - Opposition proceedings - Withdrawal of the opposition - No need to adjudicate)
(2022/C 418/50)
Language of the case: German

Parties


Applicant: Farco-Pharma GmbH (Cologne, Germany) (represented by: V. Schoene, lawyer)

Defendant: European Union Intellectual Property Office (represented by: J. Schäfer and M. Eberl, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO: Infarco, SA (Madrid, Spain)

Re:

By its action under Article 263 TFEU, the applicant seeks annulment of the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 17 January 2022 (Case R 172/2021-4).

Operative part of the order







1.


There is no longer any need to adjudicate on the action.










2.


Farco-Pharma GmbH shall bear its own costs and pay the costs incurred by the European Union Intellectual Property Office (EUIPO).






(1)  OJ C 207, 23.5.2022.